STALICLA is a mission-driven biotech startup.
Stalicla has raised €9.4M across 2 funding rounds from 1 investor, most recently a round in Jun 2025. Based in Geneva, Switzerland; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-06-30 | Other | €2.1M | Addex Therapeutics | View deal → |
| 2020-05-02 | Series A | €7.3M | — | View deal → |
